Search bioRxiv⌕ Search

Biology subjects

Minoshima, M.

Publications and source records attributed to Minoshima, M..

2 recordsLinked to original sources

Kinetic design of reversible probe exchange enables continuous single-molecule tracking beyond the photobleaching limit

Single-molecule fluorescence imaging enables direct tracking of molecular dynamics. Prolonged observation, however, is limited by photobleaching, restricting access to rare events and slow transitions. Exchangeable fluorogenic labeling has been developed to overcome this limitation, yet continuous single-molecule tracking has not been achieved. We define two quantitative kinetic conditions for continuous tracking: pre-bleach dissociation and within-frame rebinding. Mapping reported systems onto a kinetic landscape delineates the regime required for continuous tracking. To reach this regime, we turned to odorant-binding proteins, whose biological role favors rapid ligand capture and release. We paired this scaffold with high-contrast fluorogenic probes to maximize rebinding capacity while preserving rapid dissociation. The resulting system, EverGreen, sustains uninterrupted single-molecule observation for over 24 hours and establishes a general kinetic design framework beyond the photobleaching limit.

biophysics↗

Cardioluminescence in transgenic zebrafish embryos: a calcium imaging tool to study drug effects and pathological modeling

The zebrafish embryo has emerged as an excellent model in cardiovascular research. The existing techniques to monitor Ca2+ in the heart based on fluorescent Ca2+ biosensors are limited due to phototoxicity and photobleaching. To overcome these issues, we have used bioluminescence. We generated a transgenic line expressing GFP-Aequorin in the heart, Tg(cmlc2:GA), and optimized an in vivo aequorin reconstitution protocol to improve the luminescence capacity. This allowed imaging Ca2+ in long duration recordings in embryos of 3 to 5 days post-fertilization. The analogs diacetyl h-coelenterazine and f-coelenterazine enhanced the light output and signal-to-noise ratio from the embryos. With this cardioluminescence model, we monitored the time-averaged Ca2+ levels and beat-to-beat Ca2+ oscillations. Changes in Ca2+ levels were observed by incubation with BayK8644, an L-type Ca2+ channel agonist, the channel blocker nifedipine, and {beta}-adrenergic blocker propranolol. Treatment of zebrafish embryos with terfenadine for 24 hours has been proposed as a model of heart failure. Tg(cmlc2:GA) embryos treated with terfenadine showed a 2:1 atrioventricular block and a decrease in the ventricular Ca2+ levels.

physiology↗